digoxin · Azurity · NDA 009330, 020405
Lanoxin
Earliest generic entry, as listed · earliest of 4 marketed strengths
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 7
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 009330 · 002 · RLD | injectable, injection | 0.25MG/ML | open |
| 020405 · 001 · RLD | tablet, oral | 0.0625MG | open |
| 020405 · 002 · RLD | tablet, oral | 0.125MG | open |
| 020405 · 003 · RLD · discontinued | tablet, oral | 0.1875MG | open |
| 020405 · 004 · RLD | tablet, oral | 0.25MG | open |
| 020405 · 005 · discontinued | tablet, oral | 0.375MG | open |
| 020405 · 006 · discontinued | tablet, oral | 0.5MG | open |